Key Points A randomized trial found better preservation of erectile function and bladder control with TULSA than with robotic prostate surgery at six months. Additional…
Key Points Pulse Biosciences partnered with the Clayman Thyroid Center in Tampa for commercial use and clinical research involving its nPulse Vybrance System. The center…
October 14, 2026
Rhythm Launches IMCIVREE in Japan, Bringing the First Approved Treatment for Acquired Hypothalamic Obesity
Key Points Rhythm Pharmaceuticals has commercially launched IMCIVREE in Japan for acquired hypothalamic obesity. The launch follows regulatory approval in August and inclusion on Japan’s…
October 14, 2026
Arrowhead’s Under-the-Skin Tau Data Puts Brain Delivery in Focus for Alzheimer’s Stocks
Arrowhead cut spinal fluid tau by a mean of 73% without a spinal injection. Denali, Voyager and Annovis are testing other routes to lower tau….
October 13, 2026
Immuron’s Travelan Study Signals Potential for Better Protection Against Travelers’ Diarrhea
Key Points Immuron’s Phase 2 study of once-daily Travelan has been published in Scientific Reports, a journal in the Nature portfolio. The study reported a…
October 13, 2026
BrainsWay Expands Insurance Coverage for Accelerated Deep TMS to Over 70 Million U.S. Lives
Key Points BrainsWay says favorable U.S. insurance policies for its SWIFT Accelerated Deep TMS protocol now cover more than 70 million lives. The expansion creates…
October 13, 2026
Oncolytics Expands Pelareorep Patent Portfolio, Targeting Protection Into the Late 2040s
Key Points Oncolytics has secured a new patent in several countries covering pelareorep’s use as a cancer immunotherapy, with a corresponding U.S. patent expected soon….
Key Points Hims & Hers has launched Hers in Australia, expanding its women’s health services across hair regrowth, menopause, perimenopause and weight management. The launch…
October 12, 2026
vTv Therapeutics Highlights Opportunity to Improve Type 1 Diabetes Care Alongside Automated Insulin Delivery
Key Points A survey presented by vTv Therapeutics found that low blood sugar remains a concern for many adults with type 1 diabetes who use…
Key Points A real-world analysis of 470 adults with irritable bowel syndrome with constipation, or IBS-C, found fewer gastrointestinal-related healthcare visits after patients started IBSRELA….
October 12, 2026
Palisade Bio Reports Early PALI-2108 Findings Supporting Phase 2 Studies in Ulcerative Colitis and Crohn’s Disease
Key Points Palisade Bio presented five research posters on its experimental oral treatment, PALI-2108, at ACG 2026. Small, early-stage studies showed improvements in symptoms, intestinal…
October 13 is Metastatic Breast Cancer Awareness Day, which spotlights the stage of breast cancer that still has no cure and the emerging companies working…